Market revenue in 2020 | USD 183.7 million |
Market revenue in 2028 | USD 295.6 million |
Growth rate | 6.1% (CAGR from 2020 to 2028) |
Largest segment | Consumables |
Fastest growing segment | Consumables |
Historical data | 2016 - 2019 |
Base year | 2020 |
Forecast period | 2021 - 2028 |
Quantitative units | Revenue in USD million |
Market segmentation | Instruments, Consumables, Services |
Key market players worldwide | Abbott Laboratories, Thermo Fisher Scientific Inc, Koninklijke Philips NV, BD, BioMerieux SA, Bio-Rad Laboratories Inc, QuidelOrtho Corp, Siemens Healthineers AG ADR, Danaher Corp, Qiagen NV, Roche |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to infectious respiratory disease diagnostics market will help companies and investors design strategic landscapes.
Consumables was the largest segment with a revenue share of 60.15% in 2024. Horizon Databook has segmented the South Korea infectious respiratory disease diagnostics market based on instruments, consumables, services covering the revenue growth of each sub-segment from 2018 to 2030.
Increasing awareness among people and rising government support is expected to drive the growth of the infectious respiratory disease diagnostics market in South Korea. For instance, North Korea and South Korea have entered into an agreement to develop measures for combating infectious diseases, especially tuberculosis.
In addition, the increasing incidence of infectious diseases, such as pneumonia and pertussis, is expected to drive market growth. Furthermore, the country has announced that the government will cover all expenses for COVID-19 and has been effective in containing the infection rate.
Thus, this initiative is expected to boost the number of tests for COVID-19, thereby fueling the market growth. The country conducted over 1,804,422 tests as of August 24, 2020. South Korea has set up around 50 drive-through testing centers, which is expected to drive the market in the country.
Horizon Databook provides a detailed overview of country-level data and insights on the South Korea infectious respiratory disease diagnostics market , including forecasts for subscribers. This country databook contains high-level insights into South Korea infectious respiratory disease diagnostics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account